Skip to main content

Table 2 Antimicrobial resistance pattern that predict ESBL phenotype

From: Predominance of multi-resistant gram-negative bacteria colonizing chronic lower limb ulcers (CLLUs) at Bugando Medical Center

Predictive drug resistance phenotype ESBL n (%) OR (95% CI) p- value
Yes No   
AAGCS     
  Yes 12 (44.4) 15 (55.6) 3.50 (1.5-8.3) 0.004
  No 29 (18.6) 127 (81.4) 1  
AAG     
  Yes 30 (44.8) 37 (55.2) 7.74 (3.5-17.0) <0.001
  No 11(9.48) 105 (90.5) 1  
AAC     
  Yes 14 (43.8) 18 (56.3) 3.57 (1.6-8.1) 0.002
  No 27 (17.9) 124 (82.1) 1  
GCS     
  Yes 12 (42.9) 16 (57.1) 3.26 (1.4-7.6) 0.006
  No 29 (18.7) 126 (81.3) 1  
GC     
  Yes 12 (42.9) 16 (57.1) 3.26 (1.4-7.6) 0.006
  No 29 (18.7) 126 (81.3) 1  
GS     
  Yes 33 (45.8) 39 (54.2) 10.89 (4.6-25.6) <0.001
  No 8 (7.2) 103 (92.8) 1  
  1. Note: AAGCS = A- Ampicillin, A- Amoxicillin/Clavulanate, G- Gentamicin, C-Ciprofloxacin, and S- trimethoprim-sulphamethoxazole, AAG = A- Ampicillin, A- Augmentin, G- Gentamicin, AAC = A- Ampicillin, A- Augmentin, C- Ciprofloxacin, GCS = G- Gentamicin, C- Ciprofloxacin, S- trimethoprim-sulphamethoxazole, GC = G- Gentamicin, C- Ciprofloxacin, GS = G- Gentamicin, S- trimethoprim-sulphamethoxazole.
\